DK1495051T3 - Modifikation af egenskaberne af en fibrinmatrix med hensyn til vækst og indvækst af celler - Google Patents

Modifikation af egenskaberne af en fibrinmatrix med hensyn til vækst og indvækst af celler

Info

Publication number
DK1495051T3
DK1495051T3 DK03723513T DK03723513T DK1495051T3 DK 1495051 T3 DK1495051 T3 DK 1495051T3 DK 03723513 T DK03723513 T DK 03723513T DK 03723513 T DK03723513 T DK 03723513T DK 1495051 T3 DK1495051 T3 DK 1495051T3
Authority
DK
Denmark
Prior art keywords
fibrinogen
fibrin
properties
lmw
hmw
Prior art date
Application number
DK03723513T
Other languages
English (en)
Inventor
Maat Monica Petronella Maria De
Pieter Koolwijk
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tno filed Critical Tno
Application granted granted Critical
Publication of DK1495051T3 publication Critical patent/DK1495051T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • A61L24/106Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/043Proteins; Polypeptides; Degradation products thereof
    • A61L31/046Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK03723513T 2002-04-18 2003-04-07 Modifikation af egenskaberne af en fibrinmatrix med hensyn til vækst og indvækst af celler DK1495051T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1020426A NL1020426C2 (nl) 2002-04-18 2002-04-18 Modificatie van de eigenschappen van een fibrinematrix met betrekking tot groei en ingroei van cellen.
PCT/NL2003/000293 WO2003087160A1 (en) 2002-04-18 2003-04-07 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells

Publications (1)

Publication Number Publication Date
DK1495051T3 true DK1495051T3 (da) 2008-11-10

Family

ID=29244993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03723513T DK1495051T3 (da) 2002-04-18 2003-04-07 Modifikation af egenskaberne af en fibrinmatrix med hensyn til vækst og indvækst af celler

Country Status (10)

Country Link
US (2) US7867519B2 (da)
EP (1) EP1495051B1 (da)
JP (3) JP5083928B2 (da)
AT (1) ATE403679T1 (da)
AU (1) AU2003230455A1 (da)
CA (1) CA2482893C (da)
DE (1) DE60322687D1 (da)
DK (1) DK1495051T3 (da)
NL (1) NL1020426C2 (da)
WO (1) WO2003087160A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004067704A2 (en) 2003-01-30 2004-08-12 Prochon Biotech Ltd. Freeze-dried fibrin matrices and methods for preparation thereof
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US7335508B2 (en) 2004-07-22 2008-02-26 Prochon Biotech Ltd. Porous plasma protein matrices and methods for preparation thereof
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
JP2009508596A (ja) 2005-09-19 2009-03-05 ヒストジェニックス コーポレイション 細胞支持基材及びその調製方法
WO2008081463A2 (en) 2007-01-04 2008-07-10 Hepacore Ltd. Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
WO2009111069A1 (en) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
CN102089322B (zh) 2008-07-09 2015-09-23 普罗菲布瑞克斯公司 重组纤维蛋白原
WO2011083154A1 (en) * 2010-01-08 2011-07-14 Profibrix Bv Dry powder fibrin sealant
AU2011204557B2 (en) * 2010-01-08 2014-08-28 Mallinckrodt Pharma Ip Trading D.A.C. Fibrinogen preparations enriched in fibrinogen with an extended alpha chain
WO2012140650A2 (en) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof
US8999376B2 (en) 2012-02-03 2015-04-07 Xcede Technologies, Inc. Tissue patch
KR101567053B1 (ko) 2013-09-30 2015-11-09 한국원자력의학원 방사선 피폭에 의한 간 손상 예측용 바이오마커 및 그 예측방법
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
CA2994959A1 (en) 2015-08-07 2017-02-16 Xcede Technologies, Inc. Adhesive compositions and related methods
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
JP7498925B2 (ja) 2020-08-31 2024-06-13 丸一株式会社 排水栓装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009301A1 (en) * 1990-11-27 1992-06-11 The American National Red Cross Tissue sealant and growth factor containing compositions that promote accelerated wound healing
AU709134B2 (en) * 1994-05-02 1999-08-19 E.R. Squibb & Sons, Inc. Recombinant fibrin chains, fibrin and fibrin-homologs
JPH11502431A (ja) * 1995-01-16 1999-03-02 バクスター インターナショナル インコーポレイテッド 手術後の癒着を防止するための架橋化フィブリンの自己支持シート様材料
US6037457A (en) * 1997-01-31 2000-03-14 The University Of North Carolina At Chapel Hill Method for recombinant fibrinogen production
WO1998055140A1 (en) * 1997-06-05 1998-12-10 Omrix Biopharmaceuticals S.A. Fibrinogen concentrate from human plasma
US6946140B1 (en) * 1999-02-09 2005-09-20 The Research Foundation Of State University Of New York Methods and compositions for enhancing fibroblast migration
WO2000062833A1 (en) * 1999-04-15 2000-10-26 The Research Foundation Of State University Of New York Cellular matrix system and use thereof
US6613325B1 (en) * 1999-06-01 2003-09-02 Bristol-Myers Squibb Company Prevention of post surgical adhesions using a fibrin monomer sealant

Also Published As

Publication number Publication date
JP2010246543A (ja) 2010-11-04
CA2482893C (en) 2014-08-12
JP5395726B2 (ja) 2014-01-22
JP5248547B2 (ja) 2013-07-31
JP2010195805A (ja) 2010-09-09
US20110071083A1 (en) 2011-03-24
DE60322687D1 (de) 2008-09-18
AU2003230455A1 (en) 2003-10-27
NL1020426C2 (nl) 2003-10-21
JP5083928B2 (ja) 2012-11-28
CA2482893A1 (en) 2003-10-23
WO2003087160A1 (en) 2003-10-23
ATE403679T1 (de) 2008-08-15
EP1495051A1 (en) 2005-01-12
JP2005538045A (ja) 2005-12-15
US20050181972A1 (en) 2005-08-18
US7867519B2 (en) 2011-01-11
EP1495051B1 (en) 2008-08-06

Similar Documents

Publication Publication Date Title
DK1495051T3 (da) Modifikation af egenskaberne af en fibrinmatrix med hensyn til vækst og indvækst af celler
DK0625056T3 (da) Kompositmembraner til reguleret regenerering af væv
ATE262356T1 (de) Spritzbares knochenersatzmaterial enthaltend fibrin oder fibrinogen sowie hydroxylapatit zement
DK1635731T3 (da) Fremgangsmåde til forebyggelse af kirurgisk adhæsion
ATE525100T1 (de) Poröse matrix
DE69231421D1 (de) Fibrin oder fibrinogen sowie biologisch abbaubare und biokompatible polymere enthaltende zusammensetzung zur gewebebehandlung
ATE200630T1 (de) Verbundvliesstoff, enthaltend derivate von hyaluronsäure
DK1545565T3 (da) Sammensætninger, som indeholder mitotisk inaktiverede allogene fibroblaster og keratinocyter til anvendelse i regenerering af væv
NO20035569L (no) Sarbandasje og metode for kontroll av livstruende blodning
GB2348426A (en) Enzyme-mediated modification of fibrin for tissue engineering
DK1316322T3 (da) Poröse vævsstilladser til opheling og regeneration af hudvæv
WO2001050999A3 (en) Materials and methods for improved bone tendon bone transplantation
DK0730465T3 (da) Anvendelse af angiotensin III og analoger dertil til vævsreparation
WO2004034890A3 (en) Biological scaffolding material
WO2003013342A3 (en) Materials and methods for improved bone tendon bone transplantation
DK1715900T3 (da) Kompositstrukturer, som indeholder hyaluronsyre derivaterne deraf som nye knoglesubstitutter og -transplantater
DK1085917T3 (da) Biomaterialer indeholdende hyaluronsyrederivater i form af tredimensionale strukturer, som er frie for cellulære komponenter eller produkter deraf, til in vivo-regenerering af vævsceller
EP4125715A4 (en) IN VIVO TISSUE ENGINEERING DEVICES, METHODS AND REGENERATIVE AND CELLULAR MEDICINE USING ABSORBABLE MATERIAL SCAFFOLDS
WO2023081216A3 (en) Self-adherent medical implant and method of use
DE69614577D1 (de) Polyamin-antagonisten enthaltende intraokulare irrigationslösung
Kaplan et al. Rapid Stapler Tie-Over Fixation for Skin Grafts
UA36465A (uk) Спосіб ушивання глибоких і нешироких ран та голка для його здійснення